MCID: MYC007
MIFTS: 79

Myocardial Infarction

Categories: Genetic diseases, Cardiovascular diseases

Aliases & Classifications for Myocardial Infarction

MalaCards integrated aliases for Myocardial Infarction:

Name: Myocardial Infarction 57 38 12 37 29 55 6 44 15 73
Heart Attack 12 76 43 63
Myocardial Infarction 1 75 29 6
Myocardial Infarction, Decreased Susceptibility to 57 6
Myocardial Infarction, Protection Against 57 6
Myocardial Infarction, Susceptibility to, Type 1 40
Myocardial Infarction, Susceptibility to 57
Myocardial Infarction, Decreased 57
Premature Myocardial Infarction 75
Myocardial Infarct 12
Mci1 75

Classifications:



External Ids:

OMIM 57 608446
Disease Ontology 12 DOID:5844
ICD10 33 I21 I22
MeSH 44 D009203
NCIt 50 C27996
KEGG 37 H01730
UMLS 73 C0027051

Summaries for Myocardial Infarction

MedlinePlus : 43 Each year almost 800,000 Americans have a heart attack. A heart attack happens when blood flow to the heart suddenly becomes blocked. Without the blood coming in, the heart can't get oxygen. If not treated quickly, the heart muscle begins to die. But if you do get quick treatment, you may be able to prevent or limit damage to the heart muscle. That's why it's important to know the symptoms of a heart attack and call 9-1-1 if you or someone else is having them. You should call, even if you are not sure that it is a heart attack. The most common symptoms in men and women are Chest discomfort. It is often in center or left side of the chest. It usually lasts more than a few minutes. It may go away and come back. It can feel like pressure, squeezing, fullness, or pain. It also can feel like heartburn or indigestion. Shortness of breath. Sometimes this is your only symptom. You may get it before or during the chest discomfort. It can happen when you are resting or doing a little bit of physical activity. Discomfort in the upper body. You may feel pain or discomfort in one or both arms, the back, shoulders, neck, jaw, or upper part of the stomach. You may also have other symptoms, such as nausea, vomiting, dizziness, and lightheadedness. You may break out in a cold sweat. Sometimes women will have different symptoms then men. For example, they are more likely to feel tired for no reason. The most common cause of heart attacks is coronary artery disease (CAD). With CAD, there is a buildup of cholesterol and other material, called plaque, on their inner walls or the arteries. This is atherosclerosis. It can build up for years. Eventually an area of plaque can rupture (break open). A blood clot can form around the plaque and block the artery. A less common cause of heart attack is a severe spasm (tightening) of a coronary artery. The spasm cuts off blood flow through the artery. At the hospital, health care providers make a diagnosis based on your symptoms, blood tests, and different heart health tests. Treatments may include medicines and medical procedures such as coronary angioplasty. After a heart attack, cardiac rehabilitation and lifestyle changes can help you recover. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Myocardial Infarction, also known as heart attack, is related to coronary heart disease 1 and atherosclerosis susceptibility, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Myocardial Infarction is MIAT (Myocardial Infarction Associated Transcript), and among its related pathways/superpathways are Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling and Transcriptional activation by NRF2. The drugs Etanercept and Abciximab have been mentioned in the context of this disorder. Affiliated tissues include Bone and Limb, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.

UniProtKB/Swiss-Prot : 75 Myocardial infarction 1: A condition defined by the irreversible necrosis of heart muscle secondary to prolonged ischemia.

PubMed Health : 63 About heart attack: A heart attack happens when the flow of oxygen-rich blood to a section of heart muscle suddenly becomes blocked and the heart can't get oxygen. If blood flow isn't restored quickly, the section of heart muscle begins to die.Heart attacks are a leading killer of both men and women in the United States. The good news is that excellent treatments are available for heart attacks. These treatments can save lives and prevent disabilities.Heart attack treatment works best when it's given right after symptoms occur. If you think you or someone else is having a heart attack (even if you're not fully sure), call 9–1–1 right away.

Wikipedia : 76 Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops... more...

Description from OMIM: 608446

Related Diseases for Myocardial Infarction

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction

Diseases related to Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 518)
# Related Disease Score Top Affiliating Genes
1 coronary heart disease 1 34.1 ACE APOE F7
2 atherosclerosis susceptibility 33.4 APOE CDKN2B-AS1 ESR1 OLR1
3 coronary artery anomaly 33.3 ACE APOE CDKN2B-AS1 F7 ITGB3 LGALS2
4 arteries, anomalies of 32.9 ACE APOE OLR1
5 ischemic heart disease 32.5 ACE APOE F7
6 stroke, ischemic 31.9 ACE APOE CDKN2B-AS1 F7 MIAT
7 vascular disease 31.8 ACE APOE ITGB3 OLR1
8 aspirin resistance 31.2 F13A1 ITGB3
9 cerebrovascular disease 31.0 ACE APOE F7
10 alzheimer disease 30.6 ACE APOE CDKN2B-AS1 LRP8 MIAT MIR210
11 heart disease 30.5 ACE APOE F7 MIR210 MT-LIPCAR
12 acute myocardial infarction 12.6
13 inferior myocardial infarction 12.4
14 anterolateral myocardial infarction 12.3
15 myocardial infarction 2 12.3
16 posterior myocardial infarction 12.3
17 silent myocardial infarction 12.3
18 anteroseptal myocardial infarction 12.3
19 subendocardial myocardial infarction 12.3
20 acute anterolateral myocardial infarction 12.3
21 lateral myocardial infarction 12.2
22 septal myocardial infarction 12.2
23 apical myocardial infarction 12.2
24 posterolateral myocardial infarction 12.2
25 strictly posterior acute myocardial infarction 12.2
26 acute inferolateral myocardial infarction 12.2
27 posteroinferior myocardial infarction 12.2
28 inferolateral myocardial infarct 12.2
29 subendocardial infarction acute myocardial infarction 12.1
30 coronary artery disease, autosomal dominant, 1 11.9
31 coronary thrombosis 11.7
32 ventricular fibrillation, paroxysmal familial, 1 11.4
33 carotid stenosis 11.4 ACE APOE CDKN2B-AS1 F7
34 kawasaki disease 11.4
35 moderate and severe traumatic brain injury 11.3 ACE APOE
36 xanthoma disseminatum 11.3 APOE F13A1
37 werner syndrome 11.2
38 generalized atherosclerosis 11.2 ACE APOE
39 acute inferoposterior infarction 11.1
40 hyperlipidemia, familial combined 11.0
41 hyperaldosteronism, familial, type ii 11.0
42 coronary artery disease, autosomal dominant 2 11.0
43 thrombophilia due to thrombomodulin defect 11.0
44 thrombocythemia 3 11.0
45 morbid obesity and spermatogenic failure 11.0
46 chronic mountain sickness 11.0
47 hyperlipoproteinemia, type iii 11.0
48 arterial calcification of infancy 11.0
49 conn's syndrome 11.0
50 aldosterone-producing adenoma 11.0

Graphical network of the top 20 diseases related to Myocardial Infarction:



Diseases related to Myocardial Infarction

Symptoms & Phenotypes for Myocardial Infarction

Clinical features from OMIM:

608446

UMLS symptoms related to Myocardial Infarction:


angina pectoris, chest pain, edema

MGI Mouse Phenotypes related to Myocardial Infarction:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.65 F13A1 F7 GUCY1A1 ITGB3 LTA OLR1
2 homeostasis/metabolism MP:0005376 9.4 ACE APOE ESR1 F13A1 F7 GCLC

Drugs & Therapeutics for Myocardial Infarction

PubMedHealth treatment related to Myocardial Infarction: 63

Early treatment for a heart attack can prevent or limit damage to the heart muscle. Acting fast, at the first symptoms of a heart attack, can save your life. Medical personnel can begin diagnosis and treatment even before you get to the hospital.Certain treatments usually are started right away if a heart attack is suspected, even before the diagnosis is confirmed. These include: Oxygen therapy Aspirin to thin your blood and prevent further blood clottingNitroglycerin to reduce your heart's workload and improve blood flow through the coronary arteriesTreatment for chest painOnce the diagnosis of a heart attack is confirmed or strongly suspected, doctors start treatments to try to promptly restore blood flow to the heart. The two main treatments are "clot-busting" medicines and percutaneous coronary intervention (PCI), sometimes referred to as coronary angioplasty, a procedure used to open blocked coronary arteries.

Drugs for Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1042)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
2
Abciximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 143653-53-6
3
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 159351-69-6 6442177
4
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
5
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53123-88-9 5284616 6436030 46835353
6
Pravastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81093-37-0 54687
7
Colchicine Approved Phase 4,Phase 3,Phase 2,Not Applicable 64-86-8 6167 2833
8
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 120202-66-6, 113665-84-2 60606
9
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 274693-27-5 9871419
10
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 55142-85-3 5472
11
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
12
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 128270-60-0 16129704
13
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
14
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
15
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 9005-49-6 772 46507594
16
Nicorandil Approved, Investigational Phase 4,Phase 3,Not Applicable 65141-46-0 47528
17
Tirofiban Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 144494-65-5 60947
18
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable
19
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
20
Coal tar Approved Phase 4,Phase 2,Phase 1 8007-45-2
21
Ranolazine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 142387-99-3, 95635-55-5 56959
22
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable 73590-58-6 4594
23
Pantoprazole Approved Phase 4,Phase 3,Not Applicable 102625-70-7 4679
24
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 55-56-1 9552079 2713
25
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
26
Hydroxocobalamin Approved Phase 4,Phase 3,Phase 2,Not Applicable 13422-51-0 11953898 44475014
27
Chromium Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 7440-47-3 27668
28
Clonidine Approved Phase 4,Phase 3,Early Phase 1 4205-90-7 2803
29
Phenprocoumon Approved, Investigational Phase 4,Phase 3 435-97-2 9908 54680692
30
Warfarin Approved Phase 4,Phase 2,Phase 3,Not Applicable 81-81-2 6691 54678486
31
Rivaroxaban Approved Phase 4,Phase 2,Phase 3,Not Applicable 366789-02-8
32
Acenocoumarol Approved, Investigational Phase 4,Phase 3,Not Applicable 152-72-7 9052 54676537
33
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 3 69-72-7 338
34
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
35
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
36
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 169590-42-5 2662
37
Menthol Approved Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable 2216-51-5 16666
38
Cilostazol Approved, Investigational Phase 4,Phase 3,Not Applicable 73963-72-1 2754
39
Trimetazidine Approved, Investigational Phase 4,Not Applicable 5011-34-7
40
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
41
Ramipril Approved Phase 4,Phase 3,Phase 2,Not Applicable 87333-19-5 5362129
42
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 144701-48-4 65999
43
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 33069-62-4 36314
44
Amiloride Approved Phase 4,Phase 3 2016-88-8, 2609-46-3 16231
45
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 88150-42-9 2162
46
Simvastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 79902-63-9 54454
47
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 56180-94-0 441184
48
Ethanol Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 64-17-5 702
49
Ustekinumab Approved, Investigational Phase 4 815610-63-0
50
Desflurane Approved Phase 4 57041-67-5 42113

Interventional clinical trials:

(show top 50) (show all 5910)
# Name Status NCT ID Phase Drugs
1 Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction Unknown status NCT01372930 Phase 4 Etanercept;saline
2 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
3 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
4 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
5 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4 Colchicine 2 mg loading dose; 0.5 mg bid for 5 days;Placebo
6 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
7 Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Unknown status NCT01499407 Phase 4 Abciximab
8 Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function Unknown status NCT02123004 Phase 4 Ticagrelor;Clopidogrel
9 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
10 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
11 Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction. Unknown status NCT01080638 Phase 4 glycoprotein IIb/IIIa inhibitor (abciximab)
12 Thrombus Aspiration in Patients With STEMI Unknown status NCT02606435 Phase 4
13 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
14 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
15 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4 Erythropoietin
16 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
17 Effects of Intensive Statin Treatment on Left Ventricular Function Unknown status NCT01936103 Phase 4 standard group;intensive group
18 IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction Unknown status NCT00157768 Phase 4
19 Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Unknown status NCT02592694 Phase 4 cocktail
20 Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Unknown status NCT01462188 Phase 4
21 Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Unknown status NCT02792712 Phase 4 Ticagrelor;Clopidogrel
22 P3AMI Antiplatelet Trial Unknown status NCT02376283 Phase 4 Prasugrel;Clopidogrel;ticagrelor
23 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
24 Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction Unknown status NCT00888758 Phase 4
25 Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Unknown status NCT01158846 Phase 4 prasugrel/bivalirudin;clopidogrel/abciximab
26 Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Unknown status NCT01372839 Phase 4 Atorvastatin;Statin
27 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
28 Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin Unknown status NCT00370045 Phase 4 Bivalirudin with and without eptifibatide
29 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
30 Local Thrombolytics Before Thrombectomy in STEMI Unknown status NCT01568931 Phase 4 Urokinase;Saline
31 Ranolazine Loading to Prevent PCI-induced Myocardial Injury Unknown status NCT01491061 Phase 4 Ranolazine;Placebo
32 Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Unknown status NCT01968577 Phase 4 Rosuvastatin
33 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4 Ticagrelor;Clopidogrel
34 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4 Heart-protecting Musk Pill;Placebo
35 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
36 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
37 the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. Unknown status NCT02158559 Phase 4 Danhong Injection;Normal Saline
38 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
39 Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy Unknown status NCT01572129 Phase 4 Clopidogrel;Placebo
40 Polish-Italian-Hungarian RAndomized ThrombEctomy Trial Unknown status NCT00377650 Phase 4
41 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
42 A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions Unknown status NCT00825773 Phase 4
43 Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel Unknown status NCT01643031 Phase 4 Ticagrelor;Continued clopidogrel
44 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4 Tirofiban
45 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4 Colchicine
46 DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome Unknown status NCT00140257 Phase 4 Escitalopram
47 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4 Folic acid, vitamin B6 and B12 or placebo
48 Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World Unknown status NCT00768846 Phase 4
49 Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Unknown status NCT02446730 Phase 4 Prasugel;Clopidogrel
50 Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Unknown status NCT02032303 Phase 4 Ticagrelor loading;Prasugrel loading

Search NIH Clinical Center for Myocardial Infarction

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Myocardial Infarction cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Myocardial Infarction:
ADRCs, adipose-derived regenerative cells for cardiovascular disease
AMI MultiStem
AMR-001, bone marrow-derived CD34+ cells for myocardial infarction
Autologous bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow or peripheral blood-derived stem cells for treatment of myocardial ischemia
Bone marrow-derived adult mononuclear cells for heart diseases
Bone marrow-derived CD133+ vs. mononuclear cells for treatment of myocardial infarction
Bone marrow-derived mesenchymal stem cells for treatment of myocardial ischemia
Bone marrow-derived mononuclear cells for acute myocardial infarction
Bone marrow-derived mononuclear cells for chronic myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for treatment of myocardial infarction
Bone marrow-derived progenitor cells for myocardial infarction
Bone marrow-derived stem cells for treatment of ischemic cardiomyopathy
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
Cardiosphere-derived cells for the treatment of myocardial infarction
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
Combination therapy of mononuclear cells with laser for coronary disease
Early endothelial progenitor cells for acute myocardial infarction
Embryonic stem cell-derived cardiomyocyte transplantation for myocardial infarction
Embryonic stem cell-derived cardiomyocytes for treatment of myocardial infarction
Enriched bone marrow-derived progenitor cells for heart diseases
Hearticellgram
Hydrogels with cardiomyocytes for myocardial repair
Induced pluripotent stem cells for treatment of myocardial infarction
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
Mesendo, stem cell combination for treatment of cardiovascular diseases
MyoCell
Prochymal
Sca-1-positive cardiac progenitor cells for treatment of myocardial infarction
Stem cell therapy for treatment of acute myocardial infarction
StempeucelAMI
Umbilical cord blood-derived CD133 positive cells for treatment of myocardial infarction
Embryonic/Adult Cultured Cells Related to Myocardial Infarction:
Adipose-derived stem and regenerative cells PMIDs: 21082397 22281257
Bone marrow-derived adherent progenitor cells (MultiStem) PMIDs: 23111647 22004910 22052917 21175285
Bone marrow-derived autologous CD34+cells (AMR-001) PMIDs: 21167340
Bone marrow-derived mononuclear cells PMIDs: 19002124
Bone marrow-derived mononuclear cells
Peripheral blood-derived hematopoietic stem cells (family)
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Bone marrow-derived CD133+ hematopoietic stem cells
Bone marrow-derived mononuclear cells (family) PMIDs: 16889856 16382259 22192151 21414223 21392602 22940024
Bone marrow-derived mesenchymal stem cells (family)
Bone marrow-derived mononuclear cells
Bone marrow-derived mesenchymal stem cells PMIDs: 16889856 16382259
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells
Bone marrow-derived progenitor cells PMIDs: 20448133 16159812 18293890
Porcine bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024 19958962
Bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024
Cardiosphere-derived cells PMIDs: 22336189 17283259
Bone marrow-derived CD133+ cells PMIDs: 17320570
Peripheral blood-derived endothelial progenitor cells PMIDs: 21362705 22239631
eNOS-transfected endothelial progenitor cells PMIDs: 21362705 22239631
Cardiomyocyte-like cells PMIDs: 17980256 21783246
Cardiomyocyte-like cells PMIDs: 22040108
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Neonatal rat ventricular cardiomyocytes PMIDs: 21783246
DR4 induced pluripotent stem cells PMIDs: 23568891
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Bone marrow-derived mesenchymal stem cells PMIDs: 21323410 20631864
Bone marrow-derived mononuclear cells PMIDs: 21323410 20631864
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mesenchymal stem cells PMIDs: 19958962
Cardiac progenitor cells (Sca1+) PMIDs: 21980409
Bone marrow-derived CD34+/CXCR4+ cells
Bone marrow-derived mesenchymal stem cells (Stempeucel PMIDs: 18720444
Umbilical cord blood-derived CD133+ cells PMIDs: 16195418

Cochrane evidence based reviews: myocardial infarction

Genetic Tests for Myocardial Infarction

Genetic tests related to Myocardial Infarction:

# Genetic test Affiliating Genes
1 Myocardial Infarction 1 29 ESR1 F13A1 F7 GCLC GCLM ITGB3 LGALS2 LRP8 LTA MIAT OLR1 PSMA6 TNFSF4
2 Myocardial Infarction 29

Anatomical Context for Myocardial Infarction

MalaCards organs/tissues related to Myocardial Infarction:

41
Heart, Bone, Kidney, Endothelial, Testes, Brain, Bone Marrow
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Myocardial Infarction:
# Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Bone Marrow Stromal Cells Potential therapeutic candidate
2 Limb Pelvic Girdle Bone Marrow Stromal Cells Potential therapeutic candidate
3 Heart Myocardium Cardiomyocytes Affected by disease

Publications for Myocardial Infarction

Articles related to Myocardial Infarction:

(show top 50) (show all 7603)
# Title Authors Year
1
Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis. ( 29979797 )
2018
2
Silent Myocardial Infarction: Listen to the Evidence. ( 29301632 )
2018
3
MicroRNAs in pathophysiology of acute myocardial infarction and cardiogenic shock. ( 29947233 )
2018
4
Correction: Sudden death associated with silent myocardial infarction in a 35-year-old man: a case report. ( 29471871 )
2018
5
The Relationship Between Aspirin Resistance and Carotid Imaging in Young Patients With ST-Segment Elevated Myocardial Infarction: A Cross-Sectional Study. ( 29888621 )
2018
6
rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats. ( 29407168 )
2018
7
Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program. ( 29447789 )
2018
8
Circulating miR-379 as a potential novel biomarker for diagnosis of acute myocardial infarction. ( 29424915 )
2018
9
Shift work, parental cardiovascular disease and myocardial infarction in males. ( 29444274 )
2018
10
Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction. ( 29310471 )
2018
11
Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction. ( 29976694 )
2018
12
Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction. ( 29416586 )
2018
13
Toll-Like Receptors 2 and 4 Predict New-Onset Atrial Fibrillation in Acute Myocardial Infarction Patients. ( 29375116 )
2018
14
Acute Myocardial Infarction in a Patient with Isolated Dextrocardia. ( 29431312 )
2018
15
Acute myocardial infarction after blunt chest wall trauma with underlying coronary aneurysm: a case report. ( 29914384 )
2018
16
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock. ( 29424484 )
2018
17
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. ( 29446185 )
2018
18
Adiponectin gene variants and decreased adiponectin plasma levels are associated with the risk of myocardial infarction in young age. ( 29196254 )
2018
19
Non-ST Elevation Myocardial Infarction and Severe Peripheral Artery Disease in a 20-Year-Old with Perinatally Acquired Human Immunodeficiency Virus Infection. ( 29808134 )
2018
20
Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study. ( 29383439 )
2018
21
Unrecognized myocardial infarction assessed by cardiac magnetic resonance imaging is associated with adverse long-term prognosis. ( 29979788 )
2018
22
Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction. ( 29364896 )
2018
23
Atrioventricular block after acute myocardial infarction and its association with other clinical parameters in Pakistani patients: an institutional perspective. ( 29784020 )
2018
24
Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes. ( 29450734 )
2018
25
Effects of smoke-free air law on acute myocardial infarction hospitalization in Indianapolis and Marion County, Indiana. ( 29426315 )
2018
26
Optical Coherence Tomography for Guiding Plaque Stabilization in a Patient With Myocardial Infarction and Massive Coronary Thrombosis. ( 29958180 )
2018
27
Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. ( 29929933 )
2018
28
Revascularization strategies in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. ( 29909948 )
2018
29
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. ( 29452351 )
2018
30
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. ( 29400656 )
2018
31
Association of the SYNTAX Score II with cardiac rupture in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. ( 29028739 )
2018
32
Functional genetic variants in the SIRT5 gene promoter in acute myocardial infarction. ( 29981421 )
2018
33
Cardiac rupture during acute myocardial infarction diagnosed clinically. ( 29394186 )
2018
34
Accelerated idioventricular rhythm degenerating into bidirectional ventricular tachycardia following acute myocardial infarction. ( 29429799 )
2018
35
Blood cardioplegia for cardiac surgery in acute myocardial infarction: rat experiments with two widely used solutions. ( 29452370 )
2018
36
Prehospital delay in patients with ST-segment elevation myocardial infarction: time for change. ( 29979256 )
2018
37
Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST). ( 29980522 )
2018
38
Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study. ( 29021326 )
2018
39
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation. ( 29447733 )
2018
40
Buckberg's blood cardioplegia for protection of adult and senile myocardium in a rat in vitro model of acute myocardial infarction. ( 29432894 )
2018
41
Cytomegalovirus infection in a patient with systemic lupus erythematosus and acute myocardial infarction - cause or causal relationship? ( 29915649 )
2018
42
Efficacy and Safety of Cyclosporine in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. ( 29970999 )
2018
43
Delivery of a Matrix Metalloproteinase Responsive Hydrogel Releasing TIMP-3 Following Myocardial Infarction: Effects on Left Ventricular Remodeling. ( 29979624 )
2018
44
Physicians' Attitudes Towards Anticoagulation for Prevention and Treatment of Left Ventricular Thrombus Following Anterior Myocardial Infarction. ( 29980470 )
2018
45
An inferior myocardial infarction with conduction abnormalities. ( 29304949 )
2018
46
Idiopathic Sudden Sensorineural Hearing Loss Is Not a Sentinel Event for Acute Myocardial Infarction. ( 29912831 )
2018
47
A foreign older diabetic woman with an acute myocardial infarction: when cognitive biases in clinical decision-making become especially important. ( 29437739 )
2018
48
Echocardiographic Assessment of Ventricular Septal Rupture and Left Ventricular Aneurysm after Inferior and Posterior Myocardial Infarction. ( 29629264 )
2018
49
The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging. ( 29971868 )
2018
50
Clinical characteristics and value in early reperfusion therapy for new onset right bundle branch block in patients with acute myocardial infarction. ( 29467855 )
2018